Purpose: To investigate surface ablation outcomes in the COVID-19 period.
Methods: In total, 110 eyes that underwent trans-epithelium photorefractive keratectomy (TransPRK) and 93 eyes that underwent laser-assisted sub-epithelium keratectomy (LASEK) were included. Although many patients were unable to attend a follow-up for a period because of COVID-19 restrictions, doctors and patients had done lots of work to make up for it. Postoperative 6 months vision, refraction, tonometry, corneal epithelium recovery, and corneal haze were determined.
Results: All included patients gained their expected vision. The postoperative LogMAR vision at 6 months was –0.097 ± 0.022, and spherical equivalent (SE) was 0.15 ± 0.26 D. The corneal epithelium recovered at postoperative 5.38 ± 1.15 days, and vision recovered at 9.48 ± 4.12 days. Ocular hypertension was found in 18.27% of patients on postoperative day 52.95 ± 31.60, and corneal haze was found in 7.69% of patients on postoperative day 57.38 ± 22.62. The haze grade was 0.75 ± 0.53, and both hypertension and haze were controlled. TransPRK achieved faster epithelium recovery on postoperative day 8.51 ± 4.19 than LASEK (10.48 ± 3.84 days, P=0.03) and better postoperative SE than LASEK (0.11 ± 0.27D and 0.20 ± 0.25D, respectively, P=0.015).
Conclusions: TransPRK and LASEK are safe and effective for correcting refractive errors during the inconvenient COVID-19 epidemic. TransPRK might achieve faster recovery of vision and better refraction results. Nevertheless, regular visits are necessary to avoid complications such as corneal haze and corticosteroid ocular hypertension.